Biotech Drugs Will Face Competitive And Reimbursement Pressure – Analysts
Executive Summary
Increasing competition could negatively impact market potential for biotech products, Merrill Lynch's David Munno suggested
You may also be interested in...
Taxotere, Eloxatin Flat Sales Show Challenges Of Crowding Oncology Market
Nearly flat sales growth in the U.S. for Sanofi-Aventis' Eloxatin and Taxotere may be indicative of challenges facing manufacturers as more and more oncologics enter the market
Taxotere, Eloxatin Flat Sales Show Challenges Of Crowding Oncology Market
Nearly flat sales growth in the U.S. for Sanofi-Aventis' Eloxatin and Taxotere may be indicative of challenges facing manufacturers as more and more oncologics enter the market
Combo Therapy May Be Best Option For Kidney Cancer Patients, Sponsors
Developing combination regimens may provide optimal therapy for renal cell carcinoma patients and, simultaneously, allow manufacturers to avoid partitioning off the relatively limited kidney cancer market, Genentech VP-Clinical Oncology Gwen Fyfe suggested